Form 4 holding
Director, Other*, 10%+ Owner
Atara Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,209,395
- Estimated value
- $7,994,100
- Report date
- 16 May 2025
- Price
- $6.61
- Ownership
- Direct
Adiumentum Capital Fund I LP - Director, Other*, 10%+ Owner at Atara Biotherapeutics, Inc.
Issuer-level insider activity
- Role
- Director, Other*, 10%+ Owner
- Issuer ticker
- ATRA on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Adiumentum Capital Fund I LP since 12 Aug 2025
Reported holdings for Adiumentum Capital Fund I LP in Atara Biotherapeutics, Inc.
Form 4 holding
Director, Other*, 10%+ Owner
Atara Biotherapeutics, Inc.
- Security class
- Warrants (right to buy)
- Shares / value
- 377,193
- Estimated value
- $2,493,208
- Report date
- 16 May 2025
- Price
- $6.61
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Adiumentum Capital Fund I LP in Atara Biotherapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.